help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chegini, N.
Right arrow Articles by Flanders, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chegini, N.
Right arrow Articles by Flanders, K. C.

Endocrinology, Vol 135, 439-449, Copyright © 1994 by Endocrine Society

ARTICLES

Human uterine tissue throughout the menstrual cycle expresses transforming growth factor-beta 1 (TGF beta 1), TGF beta 2, TGF beta 3, and TGF beta type II receptor messenger ribonucleic acid and protein and contains [125I]TGF beta 1-binding sites

N Chegini, Y Zhao, RS Williams and KC Flanders
Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville 32610.

The use of isoform-specific transforming growth factor-beta (TGF beta) primers, 35S-labeled 40-mer oligonucleotide probes and polyclonal antibodies, reverse transcription-polymerase chain reaction, in situ hybridization, and immunohistochemical observations has revealed that human uterine tissue at various reproductive stages expresses TGF beta s and TGF beta type II receptor messenger RNAs (mRNAs) and proteins. The reverse transcription-polymerase chain reaction revealed the predicted 443-, 310-, 524-, and 431-basepair fragments for TGF beta 1, TGF beta 2, TGF beta 3, and TGF beta type II receptor, respectively, in both endometrial and myometrial tissues, which were further verified by restriction enzyme analysis. In situ hybridization and immunohistochemical observations indicated that all uterine cell types express TGF beta s mRNAs and proteins. In the functionalis region, endometrial luminal and glandular epithelial cells are the primary cell types expressing TGF beta s mRNAs and proteins, with lesser expression in stromal cells, whereas in the basalis region, they are equally expressed in both cell types. In myometrium, TGF beta mRNA and protein expression in smooth muscle cells occurs at a substantially lower level than in endometrial tissue. In endometrial tissue, the highest level of TGF beta mRNA and protein expression appeared in the late proliferative and early to midsecretory phases of the menstrual cycle, with a considerable reduction during the late secretory and postmenopausal periods. The pattern and cellular distribution of TGF beta type II receptor protein were similar to those seen with TGF beta isoforms in both endometrial and myometrial tissues. Quantitative autoradiography (net grain density per 100 microns 2) of specific binding of [125I]TGF beta 1 for different uterine cell types indicated that the stromal cells contain a higher grain density than other uterine cell types (P < 0.05), without a significantly different density in the proliferative, compared with the secretory, phase of the menstrual cycle. These data suggest that TGF beta s acting through their specific receptors may play an important role in a variety of uterine functions in an autocrine/paracrine manner, and ovarian steroids may also regulate their expression in endometrial tissue.


This article has been cited by other articles:


Home page
 EndocrinologyHome page
P. Fafet, C. Rebouissou, T. Maudelonde, and M.-L. Vignais
Opposite Effects of Transforming Growth Factor-{beta} Activation and Rho-Associated Kinase Inhibition on Human Trophoblast Migration in a Reconstituted Placental-Endometrial Coculture System
Endocrinology, September 1, 2008; 149(9): 4475 - 4485.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. P. Gaide Chevronnay, P. B. Cornet, D. Delvaux, P. Lemoine, P. J. Courtoy, P. Henriet, and E. Marbaix
Opposite Regulation of Transforming Growth Factors-{beta}2 and -{beta}3 Expression in the Human Endometrium
Endocrinology, March 1, 2008; 149(3): 1015 - 1025.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
O. Shynlova, P. Tsui, A. Dorogin, B L. Langille, and S. J Lye
The expression of transforming growth factor {beta} in pregnant rat myometrium is hormone and stretch dependent
Reproduction, September 1, 2007; 134(3): 503 - 511.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
T. Strowitzki, A. Germeyer, R. Popovici, and M. von Wolff
The human endometrium as a fertility-determining factor
Hum. Reprod. Update, September 1, 2006; 12(5): 617 - 630.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
M.R. Kim, D.W. Park, J.H. Lee, D.S. Choi, K.J. Hwang, H.S. Ryu, and C.K. Min
Progesterone-dependent release of transforming growth factor-beta1 from epithelial cells enhances the endometrial decidualization by turning on the Smad signalling in stromal cells
Mol. Hum. Reprod., November 1, 2005; 11(11): 801 - 808.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
M. Roberts, X. Luo, and N. Chegini
Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-{alpha} and TGF-{beta} in human endometrial epithelial and stromal cells
Mol. Hum. Reprod., October 1, 2005; 11(10): 751 - 760.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
C. Bruse, D. Radu, and A. Bergqvist
In situ localization of mRNA for the fibrinolytic factors uPA, PAI-1 and uPAR in endometriotic and endometrial tissue
Mol. Hum. Reprod., March 1, 2004; 10(3): 159 - 166.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
X. Luo, J. Xu, and N. Chegini
The Expression of Smads in Human Endometrium and Regulation and Induction in Endometrial Epithelial and Stromal Cells by Transforming Growth Factor-{beta}
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4967 - 4976.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
K. S. Grant and C. R. Wira
Effect of Mouse Uterine Stromal Cells on Epithelial Cell Transepithelial Resistance (TER) and TNF{alpha} and TGF{beta} Release in Culture
Biol Reprod, September 1, 2003; 69(3): 1091 - 1098.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Xu, X. Luo, and N. Chegini
Differential Expression, Regulation, and Induction of Smads, Transforming Growth Factor-{beta} Signal Transduction Pathway in Leiomyoma, and Myometrial Smooth Muscle Cells and Alteration by Gonadotropin-Releasing Hormone Analog
J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1350 - 1361.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
E. Chatzaki, E. Kouimtzoglou, A.N. Margioris, and A. Gravanis
Transforming growth factor {beta}1 exerts an autocrine regulatory effect on human endometrial stromal cell apoptosis, involving the FasL and Bcl-2 apoptotic pathways
Mol. Hum. Reprod., February 1, 2003; 9(2): 91 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Interv.Home page
W. T. Gerthoffer and C. A. Singer
Secretory Functions of Smooth Muscle: Cytokines and Growth Factors
Mol. Interv., November 1, 2002; 2(7): 447 - 456.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. R. Wira, M. A. Roche, and R. M. Rossoll
Antigen Presentation by Vaginal Cells: Role of TGF{beta} as a Mediator of Estradiol Inhibition of Antigen Presentation
Endocrinology, August 1, 2002; 143(8): 2872 - 2879.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
E. Dimitriadis, L. Robb, and L.A. Salamonsen
Interleukin 11 advances progesterone-induced decidualization of human endometrial stromal cells
Mol. Hum. Reprod., July 1, 2002; 8(7): 636 - 643.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
G. Sachdeva, V. Patil, R.R. Katkam, D.D. Manjramkar, S.D. Kholkute, and C.P. Puri
Expression Profiles of Endometrial Leukemia Inhibitory Factor, Transforming Growth Factor {beta}2 (TGF{beta}2), and TGF{beta}2 Receptor in Infertile Bonnet Monkeys
Biol Reprod, July 1, 2001; 65(1): 1 - 8.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B.-S. Lee and R. A. Nowak
Human Leiomyoma Smooth Muscle Cells Show Increased Expression of Transforming Growth Factor-{beta}3 (TGF{beta}3) and Altered Responses to the Antiproliferative Effects of TGF{beta}
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 913 - 920.
[Abstract] [Full Text]

Home page
 Mol Hum ReprodHome page
E. Chatzaki, A.N. Margioris, A. Makrigiannakis, E. Castanas, V. Georgoulias, and A. Gravanis
Kappa opioids and TGF{beta}1 interact in human endometrial cells
Mol. Hum. Reprod., July 1, 2000; 6(7): 602 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
N. Chegini, C. Ma, J. Davis, P. Duff, and C. Rosa
Differential Expression of Transforming Growth Factor-{beta}1 and Transforming Growth Factor-{beta} Receptors in Myometrium of Women With Failed Induction of Labor, No Labor, and Preterm Labor
Reproductive Sciences, September 1, 1999; 6(5): 258 - 263.
[Abstract] [PDF]

Home page
 Mol Hum ReprodHome page
N. Chegini, X.-M. Tang, and Q. Dou
The expression, activity and regulation of granulocyte macrophage-colony stimulating factor in human endometrial epithelial and stromal cells
Mol. Hum. Reprod., May 1, 1999; 5(5): 459 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
T. Sandberg,, B. Casslén,, B. Gustavsson,, and T. J. Benraad
Human Endothelial Cell Migration Is Stimulated by Urokinase Plasminogen Activator:Plasminogen Activator Inhibitor 1 Complex Released from Endometrial Stromal Cells Stimulated with Transforming Growth Factor ß1; Possible Mechanism for Paracrine Stimulation of Endometrial Angiogenesis
Biol Reprod, October 1, 1998; 59(4): 759 - 767.
[Abstract] [Full Text]

Home page
 Biol. Reprod.Home page
A. Gupta,, C. M. Dekaney,, F. W. Bazer,, M. M. Madrigal,, and L. A. Jaeger
Beta Transforming Growth Factors (TGFß) at the Porcine Conceptus-Maternal Interface. Part II: Uterine TGFß Bioactivity and Expression of Immunoreactive TGFßs (TGFß1, TGFß2, and TGFß3) and Their Receptors (Type I and Type II)
Biol Reprod, October 1, 1998; 59(4): 911 - 917.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Hatthachote, J. Morgan, W. Dunlop, G. N. Europe-Finner, and J. I. Gillespie
Gestational Changes in the Levels of Transforming Growth Factor-{beta}1 (TGF{beta}1) and TGF{beta} Receptor Types I and II in the Human Myometrium
J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2987 - 2992.
[Abstract] [Full Text]

Home page
 J. Histochem. Cytochem.Home page
M. J. Gerdes, M. Larsen, L. McBride, T. D. Dang, B. Lu, and D. R. Rowley
Localization of Transforming Growth Factor-b1 and Type II Receptor in Developing Normal Human Prostate and Carcinoma Tissues
J. Histochem. Cytochem., March 1, 1998; 46(3): 379 - 388.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
L. Zhang, I. Z. MacKenzie, M. C. P. Rees, and R. Bicknell
Regulation of the Expression of the Angiogenic Enzyme Platelet-Derived Endothelial Cell Growth Factor/ Thymidine Phosphorylase in Endometrial Isolates by Ovarian Steroids and Cytokines
Endocrinology, November 1, 1997; 138(11): 4921 - 4930.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
M. R. Ward, A. Agrotis, P. Kanellakis, R. Dilley, G. Jennings, and A. Bobik
Inhibition of Protein Tyrosine Kinases Attenuates Increases in Expression of Transforming Growth Factor-ß Isoforms and Their Receptors Following Arterial Injury
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2461 - 2470.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society